Skip to content

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors

https://pubmed.ncbi.nlm.nih.gov/28386621/

Scientists performed experiments that tested the efficacy of Mebendazole compared to that of Vincristine, another anti-parasitic drug commonly used in cancer care, and found that the use of Mebendazole increased animal survival time greater than that of Vincristine.

Share on facebook
Share on email
Share on twitter
Share on linkedin

More on Mebendazole

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments